Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

333
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
333
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

277
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
277

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep Learning Morphometric Analysis on Protocol Biopsies Predicts Future Graft Function.

Kidney international reports·2026
Same author

Comparable outcomes with anti-thymocyte globulins versus basiliximab in kidney transplantation from controlled circulatory death donors.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

Liver Transplantation for HBV-Related Disease in France: NUC Type Before LT Is Associated With Patient Survival.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical Trial.

JAMA·2026
Same author

Clinical study: Cardiovascular outcomes after a 14-week exercise intervention in young adults born preterm.

Pediatric research·2026
Same author

The risk of venous thromboembolism in kidney transplant recipients is enhanced following a cytomegalovirus infection.

Frontiers in immunology·2026

Related Experiment Video

Updated: May 30, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.7K

Should We Transplant Candidates With a Positive SARS-CoV-2 RT-PCR Test?

Ilies Benotmane1, Nathan Kasriel2, Christophe Masset3

  • 1Department of Nephrology Dialysis and Transplantation, Strasbourg University Hospital, INSERM U1109, Strasbourg, France.

Transplantation
|January 30, 2025
PubMed
Summary

Organ transplantation is safe for patients with a positive SARS-CoV-2 test if they are asymptomatic or have mild symptoms. Outcomes were favorable, with no COVID-19 related deaths in this study of solid organ transplant recipients.

More Related Videos

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

620
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.3K

Related Experiment Videos

Last Updated: May 30, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.7K
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

620
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
10:35

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

10.3K

Area of Science:

  • Transplant Surgery
  • Infectious Diseases
  • Virology

Background:

  • The safety of solid organ transplantation for SARS-CoV-2 positive candidates is uncertain due to immunosuppression risks.
  • Physicians face challenges in deciding whether to proceed with transplantation for SARS-CoV-2 positive individuals.

Purpose of the Study:

  • To evaluate the safety and outcomes of solid organ transplantation in patients with a positive SARS-CoV-2 reverse transcription polymerase chain reaction test.
  • To assess the impact of COVID-19 on immunosuppressive therapy and patient outcomes post-transplantation.

Main Methods:

  • A multicenter observational study included 65 liver or kidney transplant candidates with a positive SARS-CoV-2 test.
  • Data collected included patient demographics, COVID-19 symptoms, viral load (cycle threshold), serology, and treatment modifications.

Main Results:

  • Most patients were male (62%) with a mean age of 55.4 years.
  • Only 2 patients had symptoms, and 3 showed imaging compatible with COVID-19.
  • Outcomes were generally favorable, even with high viral loads; no deaths were attributed to COVID-19.

Conclusions:

  • Solid organ transplantation can be safely performed in asymptomatic or mildly symptomatic patients with a positive SARS-CoV-2 test.
  • A history of SARS-CoV-2 infection or immunization, alongside reassuring imaging, supports transplantation safety.